Literature DB >> 27114507

MIB-MIP is a mycoplasma system that captures and cleaves immunoglobulin G.

Yonathan Arfi1, Laetitia Minder2, Carmelo Di Primo3, Aline Le Roy4, Christine Ebel4, Laurent Coquet5, Stephane Claverol6, Sanjay Vashee7, Joerg Jores8, Alain Blanchard9, Pascal Sirand-Pugnet9.   

Abstract

Mycoplasmas are "minimal" bacteria able to infect humans, wildlife, and a large number of economically important livestock species. Mycoplasma infections include a spectrum of clinical manifestations ranging from simple fever to fulminant inflammatory diseases with high mortality rates. These infections are mostly chronic, suggesting that mycoplasmas have developed means to evade the host immune response. Here we present and functionally characterize a two-protein system from Mycoplasma mycoides subspecies capri that is involved in the capture and cleavage of IgG. The first component, Mycoplasma Ig binding protein (MIB), is an 83-kDa protein that is able to tightly bind to the Fv region of a wide range of IgG. The second component, Mycoplasma Ig protease (MIP), is a 97-kDa serine protease that is able to cleave off the VH domain of IgG. We demonstrate that MIB is necessary for the proteolytic activity of MIP. Cleavage of IgG requires a sequential interaction of the different partners of the system: first MIB captures the IgG, and then MIP is recruited to the MIB-IgG complex, enabling protease activity. MIB and MIP are encoded by two genes organized in tandem, with homologs found in the majority of pathogenic mycoplasmas and often in multiple copies. Phylogenetic studies suggest that genes encoding the MIB-MIP system are specific to mycoplasmas and have been disseminated by horizontal gene transfer. These results highlight an original and complex system targeting the host immunoglobulins, playing a potentially key role in the immunity evasion by mycoplasmas.

Entities:  

Keywords:  immunoglobulin; mycoplasmas; protease

Mesh:

Substances:

Year:  2016        PMID: 27114507      PMCID: PMC4868467          DOI: 10.1073/pnas.1600546113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Serine protease mechanism and specificity.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

2.  Identification and characterization of a site-specific tyrosine recombinase within the variable loci of Mycoplasma bovis, Mycoplasma pulmonis and Mycoplasma agalactiae.

Authors:  Yael Ron; Ravenna Flitman-Tene; Kevin Dybvig; David Yogev
Journal:  Gene       Date:  2002-06-12       Impact factor: 3.688

3.  Noncovalent association of heavy and light chains of human immunoglobulins. III. Specific interactions between VH and VL.

Authors:  C Horne; M Klein; I Polidoulis; K J Dorrington
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

4.  Immunoglobulin A protease activity of Ureaplasma urealyticum.

Authors:  J A Robertson; M E Stemler; G W Stemke
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

Review 5.  Corruption of innate immunity by bacterial proteases.

Authors:  Jan Potempa; Robert N Pike
Journal:  J Innate Immun       Date:  2009       Impact factor: 7.349

6.  Structural and functional characterization of an organic hydroperoxide resistance protein from Mycoplasma gallisepticum.

Authors:  Cheryl Jenkins; Ram Samudrala; Steven J Geary; Steven P Djordjevic
Journal:  J Bacteriol       Date:  2008-01-11       Impact factor: 3.490

7.  Association of Mycoplasma arthritidis mitogen with lethal toxicity but not with arthritis in mice.

Authors:  Wenyi Luo; Huilan Yu; Zuhua Cao; Trenton R Schoeb; Michele Marron; Kevin Dybvig
Journal:  Infect Immun       Date:  2008-09-08       Impact factor: 3.441

Review 8.  Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections.

Authors:  Thomas Prescott Atkinson; Mitchell F Balish; Ken B Waites
Journal:  FEMS Microbiol Rev       Date:  2008-08-27       Impact factor: 16.408

9.  A trigger enzyme in Mycoplasma pneumoniae: impact of the glycerophosphodiesterase GlpQ on virulence and gene expression.

Authors:  Sebastian R Schmidl; Andreas Otto; Maria Lluch-Senar; Jaume Piñol; Julia Busse; Dörte Becher; Jörg Stülke
Journal:  PLoS Pathog       Date:  2011-09-22       Impact factor: 6.823

10.  Life on arginine for Mycoplasma hominis: clues from its minimal genome and comparison with other human urogenital mycoplasmas.

Authors:  Sabine Pereyre; Pascal Sirand-Pugnet; Laure Beven; Alain Charron; Hélène Renaudin; Aurélien Barré; Philippe Avenaud; Daniel Jacob; Arnaud Couloux; Valérie Barbe; Antoine de Daruvar; Alain Blanchard; Cécile Bébéar
Journal:  PLoS Genet       Date:  2009-10-09       Impact factor: 5.917

View more
  32 in total

Review 1.  Contagious Bovine and Caprine Pleuropneumonia: a research community's recommendations for the development of better vaccines.

Authors:  Joerg Jores; Cynthia Baldwin; Alain Blanchard; Glenn F Browning; Angie Colston; Volker Gerdts; Danny Goovaerts; Martin Heller; Nick Juleff; Fabien Labroussaa; Anne Liljander; Geoffrey Muuka; Vish Nene; Ran Nir-Paz; Flavio Sacchini; Artur Summerfield; François Thiaucourt; Hermann Unger; Sanjay Vashee; Xiumei Wang; Jeremy Salt
Journal:  NPJ Vaccines       Date:  2020-07-24       Impact factor: 7.344

Review 2.  The Human Ureaplasma Species as Causative Agents of Chorioamnionitis.

Authors:  Emma L Sweeney; Samantha J Dando; Suhas G Kallapur; Christine L Knox
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

3.  Molecular mechanism of the recognition of bacterially cleaved immunoglobulin by the immune regulatory receptor LILRA2.

Authors:  Rika Yamazaki; Atsushi Furukawa; Kouyuki Hirayasu; Kohei Yumoto; Hideo Fukuhara; Hisashi Arase; Katsumi Maenaka
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

4.  Postepizootic Persistence of Asymptomatic Mycoplasma conjunctivae Infection in Iberian Ibex.

Authors:  Xavier Fernández-Aguilar; Oscar Cabezón; José Enrique Granados; Joachim Frey; Emmanuel Serrano; Roser Velarde; Francisco Javier Cano-Manuel; Gregorio Mentaberre; Arián Ráez-Bravo; Paulino Fandos; Jorge Ramón López-Olvera
Journal:  Appl Environ Microbiol       Date:  2017-07-17       Impact factor: 4.792

5.  Genome Engineering of the Fast-Growing Mycoplasma feriruminatoris toward a Live Vaccine Chassis.

Authors:  Vincent Talenton; Vincent Baby; Geraldine Gourgues; Charlotte Mouden; Stephane Claverol; Sanjay Vashee; Alain Blanchard; Fabien Labroussaa; Joerg Jores; Yonathan Arfi; Pascal Sirand-Pugnet; Carole Lartigue
Journal:  ACS Synth Biol       Date:  2022-05-05       Impact factor: 5.249

Review 6.  Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives.

Authors:  Ali Dawood; Samah Attia Algharib; Gang Zhao; Tingting Zhu; Mingpu Qi; Kong Delai; Zhiyu Hao; Marawan A Marawan; Ihsanullah Shirani; Aizhen Guo
Journal:  Front Cell Infect Microbiol       Date:  2022-05-13       Impact factor: 6.073

7.  Imaging Minimal Bacteria at the Nanoscale: a Reliable and Versatile Process to Perform Single-Molecule Localization Microscopy in Mycoplasmas.

Authors:  Fabien Rideau; Audrey Villa; Pauline Belzanne; Emeline Verdier; Eric Hosy; Yonathan Arfi
Journal:  Microbiol Spectr       Date:  2022-05-31

8.  Gene Silencing through CRISPR Interference in Mycoplasmas.

Authors:  Daria V Evsyutina; Gleb Y Fisunov; Olga V Pobeguts; Sergey I Kovalchuk; Vadim M Govorun
Journal:  Microorganisms       Date:  2022-06-05

9.  Proteases as Secreted Exoproteins in Mycoplasmas from Ruminant Lungs and Their Impact on Surface-Exposed Proteins.

Authors:  Sarah Ganter; Guylaine Miotello; Lucía Manso-Silván; Jean Armengaud; Florence Tardy; Patrice Gaurivaud; François Thiaucourt
Journal:  Appl Environ Microbiol       Date:  2019-11-14       Impact factor: 4.792

Review 10.  Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs.

Authors:  Dominiek Maes; Filip Boyen; Bert Devriendt; Peter Kuhnert; Artur Summerfield; Freddy Haesebrouck
Journal:  Vet Res       Date:  2021-05-08       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.